Stock Events

Stock Events

Novavax 

$9.78
1160
-$0.97-9.02%Friday 07:14

Statistics

Day High
9.8
Day Low
9.76
52W High
13.05
52W Low
7.84
Volume
193,244
Avg. Volume
-
Mkt Cap
1.61B
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Dividends

0%Dividend Yield
Dec 2007
$2.13
Nov 2007
$2.13
Oct 2007
$2.13
Sep 2007
$2.13
Aug 2007
$2.13
10Y Growth
N/A
5Y Growth
N/A
3Y Growth
N/A
1Y Growth
N/A

Earnings

Nov 5Expected
Q3 2025
Q1 2026
Q2 2026
Next
-1.25
-0.85
-0.46
-0.06
Expected EPS
-0.345955
Actual EPS
N/A

Financials

39.19%Profit Margin
Profitable
2020
2021
2022
2023
2024
2025
1.12BRevenue
440.3MNet Income

Analyst Ratings

$12.00Average Price Target
The highest estimate is ⁦16.00⁩.
From 2 ratings within the last 6 months. This is not an investment recommendation.
Buy
50%
Hold
0%
Sell
50%

People Also Follow

This list is based on the watchlists of people on Stock Events who follow NVAX.BOATS. It's not an investment recommendation.
Tesla
196
TSLA
Apple
187
AAPL
Microsoft
187
MSFT
Amazon
184
AMZN

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Moderna
MRNA
Mkt Cap88.52B
Moderna is a direct competitor in the mRNA vaccine space, particularly for COVID-19, similar to Novavax's efforts in vaccine development.
Pfizer
PFE
Mkt Cap173.95B
Pfizer, in collaboration with BioNTech, developed a COVID-19 vaccine that competes directly with Novavax's COVID-19 vaccine.
BioNTech
BNTX
Mkt Cap22.15B
BioNTech partners with Pfizer for the COVID-19 vaccine, making it a direct competitor to Novavax in the vaccine market.
Johnson & Johnson
JNJ
Mkt Cap657.68B
Johnson & Johnson developed a single-shot COVID-19 vaccine, competing in the same pandemic response market as Novavax.
Astrazeneca
AZN
Mkt Cap289.48B
AstraZeneca developed a COVID-19 vaccine using a different technology but competes in the same global vaccine market as Novavax.
Sanofi
SNY
Mkt Cap106.24B
Sanofi is working on COVID-19 vaccine candidates and influenza vaccines, positioning it as a competitor in the broader vaccine market.
GSK
GSK
Mkt Cap99.19B
GlaxoSmithKline, with its extensive vaccine portfolio and efforts in COVID-19 vaccine development, competes in the same space as Novavax.
Novavax
NVAX
Mkt Cap1.66B
Dynavax offers adjuvants for vaccines, making it a competitor in the broader vaccine development and enhancement market.

About

Novavax Inc is a biotechnology company that develops vaccines. The company works in the clinical stage of development with a focus on delivering novel products that prevent a broad range of diseases. It works together with its wholly owned Swedish subsidiary to produce vaccine candidates to respond to both known and emerging disease threats. The company believes its vaccine technology has the potential to be applied broadly to a wide variety of human infectious diseases. The company manages its business as one operating segment, an in-house early-stage R&D business to build a pipeline of high-value assets using its technology along with seeking to enter into partnerships to drive value creation for its assets.
Show More
CEO
ISIN
US6700024010

Listings

VI
AT
NVAX.VI
STU
DE
NVV1.STU
XETRA
DE
NVV1.XETRA
STU
DE
NVV.STU

0 Comments

Share your thoughts

FAQs

What is Novavax stock price today?▼
The current price of NVAX.BOATS is $9.78 USD — it has decreased by -9.02% in the past 24 hours. Watch Novavax stock price performance more closely on the chart.
What is Novavax stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on Boats exchange Novavax stocks are traded under the ticker NVAX.BOATS.
What is Novavax market cap?▼
Today Novavax has the market capitalization of 1.61B
When is the next Novavax earnings date?▼
Novavax is going to release the next earnings report on March 4, 2027.
What is Novavax revenue for the last year?▼
Novavax revenue for the last year amounts to 1.12B USD.
What is Novavax net income for the last year?▼
NVAX.BOATS net income for the last year is 440.3M USD.
Does Novavax pay dividends?▼
Yes, NVAX.BOATS dividends are paid monthly. The last dividend per share was 2.13 . As of today, Dividend Yield (FWD)% is 0%.
In which sector is Novavax located?▼
Novavax operates in the Other sector.
When did Novavax complete a stock split?▼
The last stock split for Novavax was on May 10, 2019 with a ratio of 1:20.